Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$24k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
6.8% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
2.0% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
8
users have liked this narrative
1
users have commented on this narrative
16
users have followed this narrative
8 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.9% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
9
users have liked this narrative
2
users have commented on this narrative
12
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
47.4% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
AMC Entertainment Holdings
AN
AnalystHighTarget
Consensus Narrative from 5 Analysts
IMAX And Dolby Cinema Upgrades Will Unlock Urban Experiential Demand
Key Takeaways Expansion of premium formats and enhanced subscription offerings are driving higher guest spending, positioning AMC for sustained margin and earnings growth beyond pre-pandemic levels. Operational efficiencies, international flagship focus, and AI-driven strategies are set to boost profitability and open new growth pathways in the evolving entertainment landscape.
View narrative
US$4.50
FV
36.4% undervalued
intrinsic discount
7.27%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
4 days ago
author updated this narrative
InnoCare Pharma
AN
AnalystHighTarget
Consensus Narrative from 8 Analysts
Rising Autoimmune Demand And China's Healthcare Modernization Will Fuel Breakthroughs
Key Takeaways Leadership in BTK inhibition and innovative drug pipeline positions the company for rapid, diversified revenue growth and major breakthroughs in multiple therapeutic areas. Strategic expansion into ADCs and strong operational efficiency create high-margin global opportunities, supporting long-term market dominance and sustained margin expansion.
View narrative
HK$23.85
FV
16.7% undervalued
intrinsic discount
41.90%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
6855
Ascentage Pharma Group International
AN
AnalystHighTarget
Consensus Narrative from 7 Analysts
Precision Oncology And Global Aging Will Open New Markets
Key Takeaways Strategic collaborations, expanding reimbursement, and efficient commercialization are set to drive recurring revenues, boost margins, and accelerate global growth. A strong, innovative pipeline and promising drug combinations position the company for durable pricing power and high-margin opportunities in precision oncology.
View narrative
HK$92.99
FV
3.2% undervalued
intrinsic discount
47.80%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Teladoc Health
AN
AnalystHighTarget
Consensus Narrative from 20 Analysts
Accelerated Digitalization And Aging Trends Will Redefine Virtual Care
Key Takeaways Expanded international offerings and AI-driven care orchestration are set to boost diversification, user retention, and long-term profitability. Enhanced insurance access and a comprehensive care platform position Teladoc to accelerate market share gains amid growing virtual care demand.
View narrative
US$12.00
FV
38.8% undervalued
intrinsic discount
2.63%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Everest Medicines
AN
AnalystHighTarget
Consensus Narrative from 8 Analysts
Expanding Healthcare Access In China Will Enlarge Rare Disease Markets
Key Takeaways Accelerated uptake of NEFECON and strong market positioning support outsized near-term revenue growth and sustained premium margins. Focus on specialty innovations and operational efficiency enables expansion into high-value markets and long-term, durable earnings growth.
View narrative
HK$79.89
FV
8.9% undervalued
intrinsic discount
83.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Veris Residential
AN
AnalystHighTarget
Consensus Narrative from 6 Analysts
Urbanization And Proptech Will Spur Multifamily Expansion
Key Takeaways Aggressive asset sales and rapid proptech adoption are improving financial strength, reducing costs, and accelerating growth in operating income and margins. Strong portfolio positioning and upcoming regulatory shifts support durable rent growth and superior occupancy, fueling long-term revenue outperformance.
View narrative
US$22.00
FV
34.5% undervalued
intrinsic discount
5.77%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Xometry
AN
AnalystHighTarget
Consensus Narrative from 9 Analysts
Digital Transformation And Distributed Manufacturing Will Unlock Secular Demand
Key Takeaways Accelerated digital transformation and integration of cloud services position Xometry to capture more market share and create recurring, high-margin revenue streams. AI automation, resilient supply chains, and monetization of marketplace offerings may lead to significant margin expansion and sustainable earnings growth.
View narrative
US$55.00
FV
16.9% undervalued
intrinsic discount
18.70%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Global Net Lease
AN
AnalystHighTarget
Consensus Narrative from 7 Analysts
Urbanization And Last Mile Logistics Will Support Real Asset Stability
Key Takeaways Rapid deleveraging, investment-grade credit, and value-creating share buybacks position the company for margin expansion and stock re-rating. Strategic focus on essential, diversified assets with European exposure enhances risk profile and attracts capital amid growing global real estate demand.
View narrative
US$12.00
FV
35.3% undervalued
intrinsic discount
-16.21%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Wave Life Sciences
AN
AnalystHighTarget
Consensus Narrative from 15 Analysts
Digital Transformation And Precision Medicine Will Drive RNA Therapeutics
Key Takeaways Innovative RNA platforms and efficient drug development pipeline position the company for rapid adoption, premium pricing, and structural expansion into high-margin, diversified markets. Lead assets demonstrate best-in-class, differentiated mechanisms with wide-ranging potential, threatening incumbents and setting up for significantly larger revenue streams and earnings growth.
View narrative
US$32.52
FV
70.8% undervalued
intrinsic discount
69.92%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Value any company in seconds
Popular companies